The results of aflibercept therapy as a first line treatment of age-related macular degeneration
Journal of Current Ophthalmology, 2019 Purpose: To report the results of aflibercept treatment in treatment-naive neovascular age-related macular degeneration (AMD) patients and suggest a suitable treatment algorithm for routine clinical practice.
Erkan Unsal, Mehmet Ozgur Cubuk
doaj +1 more source
Association of Early Anatomic Response with Visual Function in Neovascular Age-Related Macular Degeneration [PDF]
, 2021 Michael Singer +7 more
openalex +1 more source
Visual Function Assessment in Geographic Atrophy: A Review
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Geographic atrophy (GA) causes significant vision impairment and reduction in vision‐related quality of life. Fundus autofluorescence (FAF) is the gold standard of structural assessment of GA but is a surrogate marker for vision loss, which can be assessed by tests of visual function and functional vision.
Ye Li, Lauren N. Ayton, Adrian T. Fung
wiley +1 more source
An eye on long‐duration spaceflight: Controversies, countermeasures and challenges
Experimental Physiology, EarlyView.Abstract Space flight‐associated neuroocular syndrome (SANS) is a consequence of long‐duration space flight and is detected in two‐thirds of astronauts. In‐flight, this can cause a change in the refraction of the eyes, requiring graded hypermetropic ‘superfocus adjustable’ glasses, optic nerve head oedema and choroidal folds.
Vincent Wing Sum Ng +1 more
wiley +1 more source
The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited [PDF]
, 2017 BACKGROUND: To compare a near decade of follow-up, newer control cohort data, use of both the societal and third party insurer cost perspectives, and integration of unilateral/bilateral therapy on the comparative effectiveness and cost-effectiveness of ...
Adam Turpcu +4 more
core +1 more source
Re: Kunimoto et al.: Efficacy and safety of abicipar in neovascular age-related macular degeneration: 52-week results of phase 3 randomized controlled study (Ophthalmology. 2020:127:1331–1334) [PDF]
, 2021 Ashish Sharma +2 more
openalex +1 more source
Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration
Journal of Ophthalmology, 2015 Herein, we review the association between vitreomacular adhesion (VMA) and neovascular age-related macular degeneration (AMD). Meta-analyses have shown that eyes with neovascular AMD are twice as likely to have VMA as normal eyes.
Eui Chun Kang, Hyoung Jun Koh
doaj +1 more source
Rao, Anil; Chandra, Shruti; Sivaprasad, Sobha; (2022) Prediction of treatment response in patients with neovascular age-related macular degeneration [PDF]
, 2022 Anil Rao +99 more
openalex +1 more source
Implantable Drug Delivery Systems for Skeletal Muscles and Eyes
Advanced NanoBiomed Research, Volume 6, Issue 2, February 2026.This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov +8 more
wiley +1 more source
Intravitreal bevacizumab for neovascular age-related macular degeneration
Philippine Journal of Ophthalmology, 2009 Objectives: Anti-vascular endothelial growth factor (anti-VEGF) drugs delivered intravitreally have been proven effective and safe for the treatment of patients diagnosed with neovascular age-related macular degeneration (ARMD).
Junn R. Pajarillo, MD +2 more
doaj